JP2015529198A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529198A5
JP2015529198A5 JP2015528571A JP2015528571A JP2015529198A5 JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5 JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015528571 A JP2015528571 A JP 2015528571A JP 2015529198 A5 JP2015529198 A5 JP 2015529198A5
Authority
JP
Japan
Prior art keywords
compound
immunogenic carrier
conjugate
protein
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015528571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529198A (ja
JP6131415B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/055724 external-priority patent/WO2014031600A1/en
Publication of JP2015529198A publication Critical patent/JP2015529198A/ja
Publication of JP2015529198A5 publication Critical patent/JP2015529198A5/ja
Application granted granted Critical
Publication of JP6131415B2 publication Critical patent/JP6131415B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015528571A 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン Active JP6131415B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261691462P 2012-08-21 2012-08-21
US61/691,462 2012-08-21
PCT/US2013/055724 WO2014031600A1 (en) 2012-08-21 2013-08-20 Haptens of quetiapine for use in immunoassays

Publications (3)

Publication Number Publication Date
JP2015529198A JP2015529198A (ja) 2015-10-05
JP2015529198A5 true JP2015529198A5 (https=) 2016-04-14
JP6131415B2 JP6131415B2 (ja) 2017-05-24

Family

ID=49081009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015528571A Active JP6131415B2 (ja) 2012-08-21 2013-08-20 イムノアッセイに使用するためのクエチアピンのハプテン

Country Status (10)

Country Link
US (1) US9304126B2 (https=)
EP (2) EP2888257B1 (https=)
JP (1) JP6131415B2 (https=)
CN (2) CN104736536B (https=)
AU (2) AU2013305935B2 (https=)
CA (1) CA2882557C (https=)
ES (2) ES2822907T3 (https=)
PL (2) PL2888257T3 (https=)
PT (2) PT2888257T (https=)
WO (1) WO2014031600A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
JP6450314B2 (ja) * 2012-08-21 2019-01-09 ヤンセン ファーマシューティカ エヌ.ベー. クエチアピンハプテンに対する抗体及びその使用
JP6131414B2 (ja) 2012-08-21 2017-05-24 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用
PL2888257T3 (pl) * 2012-08-21 2018-02-28 Janssen Pharmaceutica Nv Hapteny kwetiapiny do zastosowania w testach immunologicznych
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
JP2015527365A (ja) 2012-08-21 2015-09-17 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンに対する抗体及びその使用
WO2014031656A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine haptens and use thereof
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールハプテンに対する抗体及びその使用
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
PL2888592T3 (pl) 2012-08-21 2018-03-30 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
EP2888284B1 (en) 2012-08-21 2022-07-06 Janssen Pharmaceutica NV Antibodies to risperidone haptens and use thereof
EP3259593B1 (en) 2015-02-20 2022-10-05 IDEXX Laboratories, Inc. Homogenous immunoassay with compensation for background signal
EP3390449A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antibodies to risperidone and use thereof
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
MX2020003523A (es) 2017-10-19 2020-07-22 Idexx Lab Inc Deteccion de dimetilarginina simetrica.
EP3934751B1 (en) 2019-03-08 2024-07-17 Mevion Medical Systems, Inc. Collimator and energy degrader for a particle therapy system
CN111808046B (zh) * 2020-06-30 2022-11-11 杭州同舟生物技术有限公司 一种喹硫平人工半抗原、人工抗原及其制备方法和应用
CN116354904B (zh) * 2023-04-26 2023-08-01 北京丹大生物技术有限公司 一种喹硫平衍生物半抗原、抗原、抗喹硫平抗体及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
PT582368E (pt) 1992-05-29 2001-05-31 Lilly Co Eli Derivados de tienobenzodiazepina para o tratamento de doencas de cns
US6034078A (en) 1992-05-29 2000-03-07 Eli Lilly And Company Limited Thienobenzodiazepine compounds
US5395933A (en) 1992-08-07 1995-03-07 Eastman Kodak Company Carbamazepine hapten analogues
US6958156B2 (en) 2000-12-15 2005-10-25 Vyrex Corporation Isoflavone derivatives
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
CA2479932A1 (en) 2002-03-28 2003-10-09 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
ATE361289T1 (de) 2002-08-05 2007-05-15 Lilly Co Eli Piperazinsubstituierte arylbenzodiazepine
US7863441B2 (en) * 2003-09-23 2011-01-04 Fermion Oy Preparation of quetiapine
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
US8076160B2 (en) * 2007-09-27 2011-12-13 Novartis Ag Drug monitoring assay
US20100069356A1 (en) 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
UY32174A (es) 2008-10-14 2010-05-31 Astrazeneca Ab Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
EP2194048A1 (en) 2008-12-02 2010-06-09 Dirk Sartor Nitrate esters for the treatment of vascular and metabolic diseases
US8715699B2 (en) 2009-12-31 2014-05-06 Kempharm, Inc. Amino acid conjugates of quetiapine, process for making and using the same
WO2011112657A1 (en) * 2010-03-11 2011-09-15 Kempharm, Inc. Fatty acid conjugates of quetiapine, process for making and using the same
US8088594B2 (en) 2010-03-16 2012-01-03 Saladax Biomedical Inc. Risperidone immunoassay
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
US8623324B2 (en) 2010-07-21 2014-01-07 Aat Bioquest Inc. Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
JP5757497B2 (ja) * 2010-10-06 2015-07-29 公立大学法人大阪府立大学 シガトキシン類ctx1bおよび54−デオキシ−ctx1bを認識するモノクローナル抗体およびそれを用いるシガトキシン類検出キット
JP5952912B2 (ja) 2011-12-15 2016-07-13 アルカーメス ファーマ アイルランド リミテッド 二級アミン化合物のプロドラッグ
PL2888257T3 (pl) * 2012-08-21 2018-02-28 Janssen Pharmaceutica Nv Hapteny kwetiapiny do zastosowania w testach immunologicznych

Similar Documents

Publication Publication Date Title
JP2015529198A5 (https=)
JP2015529197A5 (https=)
JP2015532645A5 (https=)
EP4253075A3 (en) N,n'-diarylurea derivative, manufacturing method thereof, and thermosensitive recording material using same
JP2015527363A5 (https=)
EA201200741A1 (ru) Способ получения этексилата дабигатрана
JP2017222671A5 (https=)
BR112014029578A2 (pt) composto heterocíclico fundido
UY35854A (es) Métodos para la conjugación de oxima con polipéptidos ceto-modificados
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
WO2012018907A3 (en) Polypeptides for treating and/or limiting influenza infection
CY1121484T1 (el) Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4
IL291939B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
DK1945040T3 (da) Fremgangsmåde til fremstilling af et kaffeekstrakt og det ekstrakt som opnås derved
BRPI0922972A8 (pt) Processo de preparação de ésteres ativados, bem como sal de diciclo–hexilamina
CY1123757T1 (el) Διεργασια για παρασκευη ενωσεων καρβοξαμιδιων ινδολης
WO2006042745A3 (de) Chemisch modifizierte iapp - peptidanaloga
BRPI0606676A2 (pt) processos para a preparação de derivados de ácido 4-(fenóxi-5-metil-pirimidin-4-ilóxi)piperidina-1-carboxì lico e compostos relacionados
PH12015501636B1 (en) Method for preparing 1-(4-(4-(3,4 - dichloro -2- fluorophenylamino)-7- methoxyquinazolin -6- yloxy) piperidin -1-yl) prop-2-en-1-one
WO2013132065A3 (de) Mikromechanisches messelement und verfahren zur herstellung eines mikromechanischen messelements
DK1763586T3 (da) Ny sekvens til forbedring af ekspressionen af nukleinsyre
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
EA201691510A1 (ru) Новые способы разделения горохового белка